Literature DB >> 16924062

Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.

Alireza Firooz, Amirreza Solhpour, Farzam Gorouhi, Maryam Daneshpazhooh, Kamran Balighi, Khalil Farsinejad, Mehdi Rashighi-Firoozabadi, Yahya Dowlati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16924062     DOI： 10.1001/archderm.142.8.1066

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  8 in total

1.  Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis.

Authors:  Haishan Qi; Sumin Zhao; Hong Fu; Jianping Wen; Xiaoqiang Jia
Journal:  J Ind Microbiol Biotechnol       Date:  2014-06-26       Impact factor: 3.346

2.  Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography.

Authors:  Federica Dall'Oglio; Aurora Tedeschi; Vincenzo Guardabasso; Giuseppe Micali
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

3.  Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream.

Authors:  M Goldust; E Rezaee; R Raghifar
Journal:  Ir J Med Sci       Date:  2013-05-29       Impact factor: 1.568

4.  Optimizing treatment approaches in seborrheic dermatitis.

Authors:  Goldenberg Gary
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

5.  Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?

Authors:  Güçlü Kaan Beriat; Sefik Halit Akmansu; Cem Doğan; Eren Taştan; Ferda Topal; Bizden Sabuncuoğlu
Journal:  Med Sci Monit       Date:  2012-04

6.  Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial.

Authors:  Yalda Attarzadeh; Ali Asilian; Zabihollah Shahmoradi; Neda Adibi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

Review 7.  The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Odeh Alsmeirat; Som Lakhani; Musab Egaimi; Osama Idris; Mohamed Elkhalifa
Journal:  Cureus       Date:  2022-08-02

8.  Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial.

Authors:  K Balighi; S Z Ghodsi; M Daneshpazhooh; S Ghale-Baghi; M Nasimi; A Azizpour
Journal:  Int J Womens Dermatol       Date:  2016-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.